Medicare Enrolled

Roberto Gomara

Infusion Therapy Clinic/Center · Miami, FL
3200 SW 60TH CT, Miami, FL 33155
3056616110
Registered in NPPES since 2006
NPI: 1831156066 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Gomara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Gomara? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Gomara

Roberto Gomara is an infusion therapy clinic/center specialist in Miami, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Gomara received a total of $3,297 from 30 pharmaceutical and/or device companies across 162 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Gomara is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $3,297 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,297
Total received (2018-2024)
Avg $471/year across 7 years
Top 25% in FL for infusion therapy clinic/center
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
162
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$809
2023
$586
2022
$474
2021
$390
2020
$318
2019
$366
2018
$353

Payments by company (2024)

Ipsen Biopharmaceuticals, Inc
$216
GENZYME CORPORATION
$189
Janssen Biotech, Inc.
$84
Takeda Pharmaceuticals U.S.A., Inc.
$65
Mirum Pharmaceuticals, Inc.
$57
QOL Medical, LLC
$54
Amgen Inc.
$31
Regeneron Healthcare Solutions, Inc.
$28
ABBVIE INC.
$22
ORPHALAN INC
$22
IRONWOOD PHARMACEUTICALS, INC
$20
AIMMUNE THERAPEUTICS, INC.
$19
Top 3 companies account for 60.5% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$430
Janssen Biotech, Inc.
$428
GENZYME CORPORATION
$408
Janssen Scientific Affairs, LLC
$261
Ipsen Biopharmaceuticals, Inc
$233
Medtronic, Inc.
$150
QOL Medical, LLC
$147
Nestle HealthCare Nutrition Inc.
$139
Regeneron Healthcare Solutions, Inc.
$130
Takeda Pharmaceuticals U.S.A., Inc.
$126
AbbVie Inc.
$116
Mirum Pharmaceuticals, Inc.
$98
Alexion Pharmaceuticals, Inc.
$90
Amgen Inc.
$86
ABBVIE INC.
$73
Phadia US Inc.
$65
NESTLE HEALTHCARE NUTRITION INC.
$56
Organon LLC
$29
Retrophin, Inc.
$24
Travere Therapeutics, Inc.
$24
ALBIREO PHARMA, INC.
$23
Otsuka America Pharmaceutical, Inc.
$23
ORPHALAN INC
$22
IRONWOOD PHARMACEUTICALS, INC
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
AIMMUNE THERAPEUTICS, INC.
$19
Amryt Pharma Holdings Ltd
$18
Aytu Bioscience, Inc
$14
Covidien LP
$14
PFIZER INC.
$12
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · AVSOLA · Aciphex · BREATHTEK · Bylvay · CUVRIOR · CYLTEZO · Cholbam · Creon · DUPIXENT · ENDOFLIP · EOHILIA · GATTEX · HUMIRA · Humira · INFLECTRA · ImmunoCAP · Kanuma · Linzess · Livmarli · MOTEGRITY · MYALEPT · PillCam · REMICADE · RENFLEXIS · RINVOQ · SIMPONI ARIA · SKYRIZI · STELARA · SUCRAID · Sucraid · TEPEZZA · TREMFYA · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an infusion therapy clinic/center specialist in Miami?
Compare infusion therapy clinic/centers in the Miami area by procedure volume, costs, and industry payment transparency.
Browse infusion therapy clinic/centers nearby

Geographic Context

Infusion therapy clinic/centers in nearby ZIP areas
2
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
KERALTY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Gomara is an infusion therapy clinic/center specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Gomara receive payments from pharmaceutical companies?
Yes. Gomara received a total of $3,297 from 30 companies across 162 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Gomara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →